Hepatocellular Carcinoma Clinical Trials in Gyeonggi-do
3 recruitingGyeonggi-do, South Korea
Showing 1–3 of 3 trials
Recruiting
Phase 3
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
Hepatocellular Carcinoma
AstraZeneca1,220 enrolled204 locationsNCT06921785
Recruiting
Phase 1
A Study of MT-303 in Adults With Advanced or Metastatic GPC3-Expressing Cancers, Including HCC
Hepatocellular Carcinoma
Myeloid Therapeutics70 enrolled9 locationsNCT06478693
Recruiting
Phase 1
To Evaluate the Safety, Tolerability and Preliminary Efficacy of EU307
Advanced Hepatocellular Carcinoma
Eutilex12 enrolled4 locationsNCT05783570